Pacific Biosciences of California Inc

NASDAQ: PACB
$1.77
+$0.05 (+2.9%)
Closing Price on November 21, 2024

PACB Stock Chart and Intraday Price

PACB Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry LABORATORY ANALYTICAL INSTRUMENTS
Address 1305 O'BRIEN DRIVE, MENLO PARK, CA, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 1,388.03M USD
Shares Outstanding 267,444,000
Pacific Biosciences of California, Inc., based in Menlo Park, specializes in advanced sequencing solutions aimed at unraveling complex genetic information. The company's innovative offerings include sequencing systems, consumable products like SMRT technology for long-read sequencing, and various reagent kits for DNA library preparation. Pacific Biosciences serves a diverse clientele, including research institutions, commercial labs, and pharmaceutical companies, leveraging its global sales force and distribution network. Its commitment to understanding genetic diseases is underscored by partnerships with entities like Invitae Corporation and Radboud University Medical.

PACB Articles

3 Penny Stocks to Buy With $100
Have you thought about adding penny stocks to your portfolio? You may be onto something. That is, as long as you choose the right stock picks. But there are risks to consider too. If you invest in...
Joshua Rodriguez
Published:

Prediction: This Health Care Stock Will Be the Best Performer the Rest of 2024
With a market rotation underway, where should investors seeking opportunities in health care be looking? Analysts have high expectations for Alphatec.
Trey Thoelcke
Published:

27 Companies With IPOs in 2010: Best and Worst Performers
These companies all had initial public offerings in 2010 and are still public. Their performance since then has ranged from −97% to over 16,000%.
Trey Thoelcke
Published: